European Commission approves Roche’s first-in-class bispecific antibody Lunsumio for people with relapsed or refractory follicular lymphoma
Lunsumio® (mosunetuzumab) is the first CD20xCD3 T-cell engaging bispecific antibody available to treat the most…
Islamic Finance Takes Center Stage as a Driver of Sustainable Economic Growth at Global Forum
OMP and Eastman Show Decision Velocity in Practice at Gartner Supply Chain Planning Summit 2026
OpenWorld Signs Term Sheet to Finance Solar-Powered, Distributed AI Computing Network Initially Integrated with Residential Battery Storage with Tokenized Financing Program of up to $1 Billion
SenesTech Reports Record Preliminary Third Quarter Revenue Exceeding $1 Million, the Highest in Company History, with 40% Sequential Growth
Focus Graphite Advances Lac Knife Toward Construction Readiness with Up to C$1.93 Million in Combined Government Infrastructure Support